Preoperative radiation response evaluated by 18-fluorodeoxyglucose positron emission tomography predicts survival in locally advanced rectal cancer

Diseases of the Colon and Rectum

Volumn 51, Issue 7, 2008, Pages 1055-1060

  Nakagawa, Keiichi ^a   Yamashita, Hideomi ^a   Nakamura, Naoki ^a   Igaki, Hiroshi ^a   Tago, Masao ^a   Hosoi, Yoshio ^a   Momose, Toshimitsu ^a   Ohtomo, Kuni ^a   Muto, Tetsuichiro ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Positron emission tomography; Preoperative radiation; Prognostic value; Radiotherapy; Rectal cancer; Standardized uptake values

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; APPARATUS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE TREATMENT; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RECTUM CANCER; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

COLECTOMY; COLOSTOMY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 46649100459     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9243-2     Document Type: Article

References (50)

1. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of randomized study (EORTC). Ann Surg 1988;208:606-14.
2. Anonymous. Preoperative short-term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer 1990;66:49-55.
3. Anonymous. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
4. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-304.
5. Mendenhall WM, Millon RR, Bland KI, Pfaff WW, Copeland EM. Preoperative radiotherapy for clinically resectable adenocarcinoma of the rectum. Ann Surg 1985;202:215-22.
6. Mohiuddin M, Marks G. Patterns of recurrence following high-dose preoperative radiation and sphincter-preserving surgery for cancer of the rectum. Dis Colon Rectum 1993;36:117-26.
7. Mohiuddin M, Marks G. High dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys 1991;20:37-43.
8. Ng AK, Recht A, Busse PM. Sphincter preservation therapy for distal rectal carcinoma: a review. Cancer 1997;79:671-83.
9. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994;30:845-9.
10. Willett CG. Organ preservation in anal and rectal cancers. Curr Opin Oncol 1996;8:329-33.
11. Harms BA, Starling JR. Current status of sphincter preservation in rectal cancer. Oncology (Williston Park) 1990;4:53-60.
12. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B; Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902.
13. Herrera L, Brown MT. Prognostic profile in rectal cancer. Dis Colon Rectum 1994;37:S1-5.
14. Tang R, Wang JY, Chen JS, et al. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg 1995;180:705-12.
15. Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982;144:350-4.
16. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999;79:191-203.
17. Dershaw DD, Enker WE, Cohen AM, Sigurdson ER. Transrectal ultrasonography of rectal carcinoma. Cancer 1990;66:2336-40.
18. Wang WS, Lin JK, Chiou TJ, et al. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 2000;30:12-6.
19. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
20. Lanza G, Matteuzzi M, Gafa R, et al. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 1998;79:390-5.
21. Rinkus KM, Russell GB, Levine EA. Prognostic significance of nodal disease following preoperative radiation for rectal adenocarcinoma. Ann Surg 2002;68:482-7.
22. Myerson RJ, Michalski JM, King ML, et al. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys 1995;32:547-8.
23. Onaitis MW, Noone RB, Hartwig M, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 2001;233:778-85.
24. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895-903.
25. Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075-80.
26. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 1997;21:728-32.
27. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989;32:307-15.
28. Minsky BD. Adjuvant therapy for rectal cancer: the transatlantic view. Colorectal Dis 2003;5:416-22.
29. Rodel C, Sauer R. Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer. Semin Surg Oncol 2001;20:3-12.
30. Wils J, O'Dwyer P, Labianca R. Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. Ann Oncol 2001;12:13-22.
31. Guillem JG, Moore HG, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining long term outcomes of rectal cancer. J Am Coll Surg 2004;199:1-7.
32. Oku S, Nakagawa K, Momose T, et al. FDG-PET after radiotherapy is a good prognosis indicator of rectal cancer. Ann Nucl Med 2002;16:409-16.
33. Kanno I, Iida H, Miura S, et al. Design concepts and preliminary performances of stationary-sampling whole-body high-resolution positron emission tomography: HEADTOME IV [in Japanese]. Kaku Igaku 1989;26:477-85.
34. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993;189:847-50.
35. The Japanese Society for Esophageal Disease. Histopathologic criteria for the effects of radiation or anticancer chemotherapy. In: Isono K, ed. Guidelines for clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara Shuppan, 1999:55.
36. Greven KM, Williams DW III, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001;23:942-6.
37. Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20:1398-404.
38. Rege S, Safa AA, Chaiken L, Hoh C, Juillard G, Withers HR. Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 2000;23:164-9.
39. Kunkel M, Forster GJ, Reichert TE, et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol 2003;39:170-7.
40. Brun E, Ohlsson T, Erlandsson K, et al. Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET. Acta Oncol 1997;36:741-7.
41. Swisher SG, Erasmus J, Maish M, et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004;101:1776-85.
42. Kunkel M, Grotz KA, Forster GJ, et al. Therapy monitoring with 2-(18F)-FDG positron emission tomography after neoadjuvant radiation treatment of mouth carcinoma [in German]. Srahlenther Onkol 2001;177:145-52.
43. Brücher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001;233:300-9.
44. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002;13:361-8.
45. de Geus-Oei LF, Wiering B, Krabbe PF, Ruers TJ, Punt CJ, Oyen WJ. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma. Ann Oncol 2006;17:1650-5.
46. Akhurst T, Kates TJ, Mazumdar M, et al. Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005;23:8713-6.
47. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-5.
48. Guillem JG, Puig-La Calle J Jr, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18-24.
49. Denecke T, Rau B, Hoffmann KT, et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 2005;15:1658-66.
50. Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006;47:14-22.